Nanjiang Hou
- Oncology top 10%
- Pathology and Forensic Medicine top 5%
- Molecular Biology
- Emergency Medicine top 5%
- Cancer Research
- Co-authors
- Alfred RademakerV. Craig JordanMonica MorrowMark HolodniyRobert T. ChattertonVandana SundaramDouglas K OwensIngram Olkin
- Topics
- BRCA gene mutations in cancer (5 papers)Breast Cancer Treatment Studies (5 papers)Cancer Risks and Factors (4 papers)
- Partner nations
- United StatesEgyptSpain
In The Last Decade
Nanjiang Hou
17 papers receiving 628 citations
Peers
Comparison fields: 5 of 87
- Oncology 261
- Pathology and Forensic Medicine 232
- Molecular Biology 134
- Emergency Medicine 132
- Cancer Research 114
Countries citing papers authored by Nanjiang Hou
This map shows the geographic impact of Nanjiang Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanjiang Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanjiang Hou more than expected).
Fields of papers citing papers by Nanjiang Hou
This network shows the impact of papers produced by Nanjiang Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanjiang Hou. The network helps show where Nanjiang Hou may publish in the future.
Co-authorship network of co-authors of Nanjiang Hou
This figure shows the co-authorship network connecting the top 25 collaborators of Nanjiang Hou. A scholar is included among the top collaborators of Nanjiang Hou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanjiang Hou. Nanjiang Hou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 162 | |
| 5 | 30 | |
| 6 | 13 | |
| 7 | 18 | |
| 8 | 37 | |
| 9 | 54 | |
| 10 | 16 | |
| 11 | 65 | |
| 12 | 22 | |
| 13 | 15 | |
| 14 | 2 | |
| 15 | 66 | |
| 16 | 69 | |
| 17 | 73 | |
| 18 | [Usefulness of 99mTc-tetrofosmin myocardial scintigraphy before and after coronary intervention]. | 2 |
About Nanjiang Hou
Nanjiang Hou is a scholar working on Cancer Research, Oncology and Behavioral Neuroscience, having authored 18 papers that have together received 646 indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (5 papers), Breast Cancer Treatment Studies (5 papers) and Cancer Risks and Factors (4 papers). The work is most often cited by research in Emergency Medicine (132 citations), Pathology and Forensic Medicine (232 citations) and Virology (58 citations). Nanjiang Hou has collaborated with scholars based in United States, Egypt and Spain. Frequent co-authors include Alfred Rademaker, V. Craig Jordan, Monica Morrow, Mark Holodniy, Robert T. Chatterton, Vandana Sundaram, Douglas K Owens, Ingram Olkin, Eran Bendavid and Katherine E. Niehaus. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.